Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
PaperCitations, authors & open-access status
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 332 citations, 2011 year and closed oa status.
332
Citations
2011
Year
closed
OA Status